/5
0 avis
CRISPR/Cas9-mediated genetic correction of Familial Hypercholesterolemia type IIA patient-specific induced pluripotent stem cells restores LDLR functionality and promotes productive hepatitis C virus (HCV) infection after hepatocytic differentiation
Archive ouverte
Edité par CCSD -
International audience
Consulter en ligne
Chargement des enrichissements...